Business · 18/01/2011Updated: 10/17/2026 · 1 min read
FDA Amends Animal Drug Regulations Due to Sponsor Change for Hemoglobin Glutamer-200
Summary
The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect a change in sponsorship for hemoglobin glutamer-200 from Biopure Corp. to OPK Biotech, LLC.
Original source language: Federal Register — Health and Human ServicesOpen original release →